INTERNATIONAL PATENT: HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING METFORMIN AND EMPAGLIFLOZIN WITH IMPROVED DISSOLUTION RATE AND PRODUCTIVITY"

GENEVA, Feb. 10 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeonHwaseong-siGyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/011331) for "PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING METFORMIN AND EMPAGLIFLOZIN WITH IMPROVED DISSOLUTION RATE AND PRODUCTIVITY" on Jul 30, 2025. With publication no. WO/2026/029559, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization ...